Review article · 2024 · Open access

Theranostic nanoparticles for detection and treatment of pancreatic cancer

Happy Agarwal, Ryan C. Bynum, Nada Saleh, Danielle Harris, William M. MacCuaig, Vung Kim, Emma J. Sanderson, Isabel S. Dennahy, Rohit Singh, Bahareh Behkam, Jorge G. Gómez-Gutiérrez, Ajay Jain and 2 more

Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, 16(4), e1983 · Published 1 July 2024 · DOI 10.1002/wnan.1983

Open full textCite this paper

In brief

“Theranostic nanoparticles for detection and treatment of pancreatic cancer” is a 2024 review article by Happy Agarwal and 13 co-authors, published in Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. OpenAlex counts 21 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology.

Citations
21
Most cited in
2025 (11)
Field-weighted impact
0.48
References
271
Authors
14

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most recalcitrant cancers due to its late diagnosis, poor therapeutic response, and highly heterogeneous microenvironment. Nanotechnology has the potential to overcome some of the challenges to improve diagnostics and tumor-specific drug delivery but they have not been plausibly viable in clinical settings. The review focuses on active targeting strategies to enhance pancreatic tumor-specific uptake for nanoparticles. Additionally, this review highlights using actively targeted liposomes, micelles, gold nanoparticles, silica nanoparticles, and iron oxide nanoparticles to improve pancreatic tumor targeting. Active targeting of nanoparticles toward either differentially expressed receptors or PDAC tumor microenvironment (TME) using peptides, antibodies, small molecules, polysaccharides, and hormones has been presented. We focus on microenvironment-based hallmarks of PDAC and the potential for actively targeted nanoparticles to overcome the challenges presented in PDAC. It describes the use of nanoparticles as contrast agents for improved diagnosis and the delivery of chemotherapeutic agents that target various aspects within the TME of PDAC. Additionally, we review emerging nano-contrast agents detected using imaging-based technologies and the role of nanoparticles in energy-based treatments of PDAC. This article is categorized under: Implantable Materials and Surgical Technologies > Nanoscale Tools and Techniques in Surgery Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Diagnostic Tools > In Vivo Nanodiagnostics and Imaging.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Agarwal, H., Bynum, R. C., Saleh, N., Harris, D., MacCuaig, W. M., Kim, V., Sanderson, E. J., Dennahy, I. S., Singh, R., Behkam, B., Gómez-Gutiérrez, J. G., Jain, A., Edil, B. H., & McNally, L. R. (2024). Theranostic nanoparticles for detection and treatment of pancreatic cancer. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, 16(4), e1983. https://doi.org/10.1002/wnan.1983

MLA 9

Agarwal, Happy, et al. “Theranostic nanoparticles for detection and treatment of pancreatic cancer.” Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, vol. 16, no. 4, 2024, p. e1983. https://doi.org/10.1002/wnan.1983.

Chicago

Agarwal, Happy, Ryan C. Bynum, Nada Saleh, Danielle Harris, William M. MacCuaig, Vung Kim, Emma J. Sanderson, et al. 2024. “Theranostic nanoparticles for detection and treatment of pancreatic cancer.” Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology 16 (4): e1983. https://doi.org/10.1002/wnan.1983.

Harvard

Agarwal, H. et al. (2024) ‘Theranostic nanoparticles for detection and treatment of pancreatic cancer’, Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, 16(4), p. e1983. doi:10.1002/wnan.1983.

IEEE

H. Agarwal et al., “Theranostic nanoparticles for detection and treatment of pancreatic cancer,” Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, vol. 16, no. 4, p. e1983, 2024, doi: 10.1002/wnan.1983.

BibTeX

@article{agarwal2024theranostic,
  title     = {{Theranostic nanoparticles for detection and treatment of pancreatic cancer}},
  author    = {Agarwal, Happy and Bynum, Ryan C. and Saleh, Nada and Harris, Danielle and MacCuaig, William M. and Kim, Vung and Sanderson, Emma J. and Dennahy, Isabel S. and Singh, Rohit and Behkam, Bahareh and Gómez-Gutiérrez, Jorge G. and Jain, Ajay and Edil, Barish H. and McNally, Lacey R.},
  journal   = {Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology},
  year      = {2024},
  volume    = {16},
  number    = {4},
  pages     = {e1983},
  doi       = {10.1002/wnan.1983},
  url       = {https://doi.org/10.1002/wnan.1983}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202411
20251111
202699

Its field-weighted citation impact is 0.48: it has been cited 0.48 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • pancreatic ductal adenocarcinoma
  • theranostic nanoparticles
  • active targeting
  • tumor microenvironment
  • liposomes
  • micelles
  • gold nanoparticles
  • silica nanoparticles

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Agarwal, H., Bynum, R. C., Saleh, N., Harris, D., MacCuaig, W. M., Kim, V., Sanderson, E. J., Dennahy, I. S., Singh, R., Behkam, B., Gómez-Gutiérrez, J. G., Jain, A., Edil, B. H., & McNally, L. R. (2024). Theranostic nanoparticles for detection and treatment of pancreatic cancer. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, 16(4), e1983. https://doi.org/10.1002/wnan.1983

How many times has this paper been cited?

21 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology: sign in and open the full text from this page.

Who wrote this paper?

Happy Agarwal, Ryan C. Bynum, Nada Saleh, Danielle Harris, William M. MacCuaig, Vung Kim, Emma J. Sanderson, Isabel S. Dennahy, Rohit Singh, Bahareh Behkam, Jorge G. Gómez-Gutiérrez, Ajay Jain and 2 more.

What is the DOI of this paper?

10.1002/wnan.1983, permanently at https://doi.org/10.1002/wnan.1983. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.